BioArctic's Partner Eisai to Present Update on the Development of BAN2401 at Alzheimer's Association International Conference 2020 |
| July 22, 2020 | July 2020 Bond Updates |
|
STOCKHOLM, July 22, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company's partner Eisai will present the study design of the Phase 3 program AHEAD 3-45 at the Alzheimer's Association International Conference 2020 (AAIC®) on July 27-31. In... |
| View more at: https://www.prnewswire.com:443/news-releases/bioarctics-partner-eisai-to-present-update-on-the-development-of-ban2401-at-alzheimers-association-international-conference-2020-301097673.html |